QuickView for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=86A2AA8A39E51C0F450049D37E597C04;jsessionid=C1188DFB6C25D0C9A6AAC30CD302840A;jsessionid=248F3DAA0A3B49CFFA500CD72A63A70F;jsessionid=C67CEBE5A85BA045792DB11B72792BB2;jsessionid=C79983CB695E2B5F2A5E286293A13D2E;jsessionid=41E7C337279B1646D1E50FD1034F69B0 (gene)

1. Thymic stroma and TFII-I: towards new targeted therapies.
2. Proteomic analysis of SRF associated transcription complexes identified TFII-I as modulator of SRF f…
3. Structural basis for evolutionarily conserved interactions between TFIIS and Paf1C.
4. The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and dis…
5. Identification of novel regulatory NFAT and TFII-I binding elements in the calbindin-D28k promoter i…

There were no clinical trials for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=86A2AA8A39E51C0F450049D37E597C04;jsessionid=C1188DFB6C25D0C9A6AAC30CD302840A;jsessionid=248F3DAA0A3B49CFFA500CD72A63A70F;jsessionid=C67CEBE5A85BA045792DB11B72792BB2;jsessionid=C79983CB695E2B5F2A5E286293A13D2E;jsessionid=41E7C337279B1646D1E50FD1034F69B0